首页> 外国专利> 'development and validation of stability indicating reverse phase-ultra performance liquid chromatography (rp-uplc) method for determination of prenoxdiazine hc1 in its bulk form'

'development and validation of stability indicating reverse phase-ultra performance liquid chromatography (rp-uplc) method for determination of prenoxdiazine hc1 in its bulk form'

机译:“稳定性的发展和验证,表明用于测定散装形式的普瑞诺二嗪HC1的反相超高效液相色谱(rp-uplc)方法”

摘要

The method having a purpose of reducing analysis time, increasing reliability via higher resolution with very high pressure due to smaller particles, sensitivity and selectivity as well as economical method by reducing solvent consumption, Reverse Phase-Ultra performance Liquid Chromatography (RP-UPLC) is most promising advancement in a world of chromatography. Being a patented drug, Prenoxdiazine HC1 has not any published analytical background. In this novel research work, a new gradient reverse phase UPLC method was developed for the same in bulk form. Forced degradation study was carried out as per International Conference on Harmonization (ICH) guideline and a newly developed method is applicable to degradation analysis of drug. A chromatographic separation of drug as well as its degradants was achieved using Waters acquity CSH, 2.1 x 100mm, 1.7μm C18 column with gradient of phosphate buffer pH 7.0 and acetonitrile. Drug and degradants were monitored at detection wavelength of 220 nm, the flow rate was 0.4 ml/min, injection volume was 5 μl and temperature of column and auto sampler compartments were ambient. Retention time of drug was about 2.9 mins and relative retention time of common degradant in all stressed conditions is 0.92. The resolution of drug and degradant was greater than 1.7 in all cases. At higher stressed conditions, drug degrades into more fragments as compare to one degradant n optimized stressed condition. Drug shows different solution stability in two different diluents that are acetonitrile and methanol. A developed method was validated as per ICH guideline using validation parameters like precision, linearity and range, specificity, robustness, solution stability and filter compatibility. Results of validation were found satisfactorily within specified acceptance criteria. Forced degradation studies demonstrated the stability indicating power of the UPLC method.
机译:反相,超高效液相色谱(RP-UPLC)是一种旨在减少分析时间,通过更高分辨率,更高的分辨率(由于较小的颗粒,灵敏度和选择性)而提高可靠性,以及通过减少溶剂消耗而经济的方法。色谱领域最有希望的进展。作为一种专利药物,Prenoxdiazine HC1没有任何公开的分析背景。在这项新颖的研究工作中,针对相同的本体形式开发了一种新的梯度反相UPLC方法。根据国际协调会议(ICH)指南进行了强制降解研究,一种新开发的方法适用于药物的降解分析。使用Waters acquity CSH,2.1 x 100mm,1.7μmC18色谱柱和pH 7.0的磷酸盐缓冲液和乙腈进行梯度分离,可实现药物及其降解物的色谱分离。在220 nm的检测波长下监测药物和降解物,流速为0.4 ml / min,进样量为5μl,色谱柱和自动进样器的温度为室温。在所有压力条件下,药物的保留时间约为2.9分钟,普通降解物的相对保留时间为0.92。在所有情况下,药物和降解物的分离度均大于1.7。在较高的压力条件下,与一种降解物在最佳压力条件下相比,药物降解为更多的碎片。药物在乙腈和甲醇这两种不同的稀释剂中显示出不同的溶液稳定性。按照ICH指南,使用诸如精密度,线性和范围,特异性,鲁棒性,溶液稳定性和过滤器相容性等验证参数对一种开发的方法进行了验证。在指定的接受标准内令人满意地找到了验证结果。强迫降解研究表明,稳定性表明了UPLC方法的强大功能。

著录项

  • 公开/公告号IN2013MU03342A

    专利类型

  • 公开/公告日2015-07-17

    原文格式PDF

  • 申请/专利权人 PARUL AROGYA SEVA MANDAL;

    申请/专利号IN2013MUM3342

  • 发明设计人 NAGAR AKHIL;SHAH RONAK;RAJESH KS;

    申请日2013-10-24

  • 分类号G01N30/36;C07D495/04;

  • 国家 IN

  • 入库时间 2022-08-21 15:14:15

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号